Global Viable Tumors Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Viable Tumor Samples market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viable Tumor Samples Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viable Tumor Samples market in any manner.
Global Viable Tumor Samples Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
StoreMyTumor
Cureline, Inc.
Conversant Bio
Fluxion Biosciences
Miltenyi Biotech
Crown Bioscience, Inc.
Indivumed GmbH
Illumina, Inc.
QIAGEN NV
Neogenomics Laboratories, Inc.
HTG Molecular Diagnostics
Genomic Health, Inc.
Thermo Fischer
BGI Genomics Co., Ltd.
Bruker Biosciences Corp.
Cepheid, Inc.
Promega Corporation
Applied Biosystems, Inc.
Natera
Agilent
Market Segmentation (by Type)
Flash Frozen Tumor Samples
Fresh Tumor Samples
Market Segmentation (by Application)
Lung Cancer
Prostate Cancer
Breast Cancer
Lymphoma
Leukemia
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viable Tumor Samples Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Viable Tumor Samples market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viable Tumor Samples Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viable Tumor Samples market in any manner.
Global Viable Tumor Samples Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
StoreMyTumor
Cureline, Inc.
Conversant Bio
Fluxion Biosciences
Miltenyi Biotech
Crown Bioscience, Inc.
Indivumed GmbH
Illumina, Inc.
QIAGEN NV
Neogenomics Laboratories, Inc.
HTG Molecular Diagnostics
Genomic Health, Inc.
Thermo Fischer
BGI Genomics Co., Ltd.
Bruker Biosciences Corp.
Cepheid, Inc.
Promega Corporation
Applied Biosystems, Inc.
Natera
Agilent
Market Segmentation (by Type)
Flash Frozen Tumor Samples
Fresh Tumor Samples
Market Segmentation (by Application)
Lung Cancer
Prostate Cancer
Breast Cancer
Lymphoma
Leukemia
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Viable Tumor Samples Market
- Overview of the regional outlook of the Viable Tumor Samples Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viable Tumor Samples Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Viable Tumor Samples
1.2 Key Market Segments
1.2.1 Viable Tumor Samples Segment by Type
1.2.2 Viable Tumor Samples Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIABLE TUMOR SAMPLES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Viable Tumor Samples Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Viable Tumor Samples Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIABLE TUMOR SAMPLES MARKET COMPETITIVE LANDSCAPE
3.1 Global Viable Tumor Samples Sales by Manufacturers (2019-2024)
3.2 Global Viable Tumor Samples Revenue Market Share by Manufacturers (2019-2024)
3.3 Viable Tumor Samples Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Viable Tumor Samples Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Viable Tumor Samples Sales Sites, Area Served, Product Type
3.6 Viable Tumor Samples Market Competitive Situation and Trends
3.6.1 Viable Tumor Samples Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viable Tumor Samples Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VIABLE TUMOR SAMPLES INDUSTRY CHAIN ANALYSIS
4.1 Viable Tumor Samples Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIABLE TUMOR SAMPLES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VIABLE TUMOR SAMPLES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viable Tumor Samples Sales Market Share by Type (2019-2024)
6.3 Global Viable Tumor Samples Market Size Market Share by Type (2019-2024)
6.4 Global Viable Tumor Samples Price by Type (2019-2024)
7 VIABLE TUMOR SAMPLES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viable Tumor Samples Market Sales by Application (2019-2024)
7.3 Global Viable Tumor Samples Market Size (M USD) by Application (2019-2024)
7.4 Global Viable Tumor Samples Sales Growth Rate by Application (2019-2024)
8 VIABLE TUMOR SAMPLES MARKET SEGMENTATION BY REGION
8.1 Global Viable Tumor Samples Sales by Region
8.1.1 Global Viable Tumor Samples Sales by Region
8.1.2 Global Viable Tumor Samples Sales Market Share by Region
8.2 North America
8.2.1 North America Viable Tumor Samples Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viable Tumor Samples Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viable Tumor Samples Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viable Tumor Samples Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viable Tumor Samples Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 StoreMyTumor
9.1.1 StoreMyTumor Viable Tumor Samples Basic Information
9.1.2 StoreMyTumor Viable Tumor Samples Product Overview
9.1.3 StoreMyTumor Viable Tumor Samples Product Market Performance
9.1.4 StoreMyTumor Business Overview
9.1.5 StoreMyTumor Viable Tumor Samples SWOT Analysis
9.1.6 StoreMyTumor Recent Developments
9.2 Cureline, Inc.
9.2.1 Cureline, Inc. Viable Tumor Samples Basic Information
9.2.2 Cureline, Inc. Viable Tumor Samples Product Overview
9.2.3 Cureline, Inc. Viable Tumor Samples Product Market Performance
9.2.4 Cureline, Inc. Business Overview
9.2.5 Cureline, Inc. Viable Tumor Samples SWOT Analysis
9.2.6 Cureline, Inc. Recent Developments
9.3 Conversant Bio
9.3.1 Conversant Bio Viable Tumor Samples Basic Information
9.3.2 Conversant Bio Viable Tumor Samples Product Overview
9.3.3 Conversant Bio Viable Tumor Samples Product Market Performance
9.3.4 Conversant Bio Viable Tumor Samples SWOT Analysis
9.3.5 Conversant Bio Business Overview
9.3.6 Conversant Bio Recent Developments
9.4 Fluxion Biosciences
9.4.1 Fluxion Biosciences Viable Tumor Samples Basic Information
9.4.2 Fluxion Biosciences Viable Tumor Samples Product Overview
9.4.3 Fluxion Biosciences Viable Tumor Samples Product Market Performance
9.4.4 Fluxion Biosciences Business Overview
9.4.5 Fluxion Biosciences Recent Developments
9.5 Miltenyi Biotech
9.5.1 Miltenyi Biotech Viable Tumor Samples Basic Information
9.5.2 Miltenyi Biotech Viable Tumor Samples Product Overview
9.5.3 Miltenyi Biotech Viable Tumor Samples Product Market Performance
9.5.4 Miltenyi Biotech Business Overview
9.5.5 Miltenyi Biotech Recent Developments
9.6 Crown Bioscience, Inc.
9.6.1 Crown Bioscience, Inc. Viable Tumor Samples Basic Information
9.6.2 Crown Bioscience, Inc. Viable Tumor Samples Product Overview
9.6.3 Crown Bioscience, Inc. Viable Tumor Samples Product Market Performance
9.6.4 Crown Bioscience, Inc. Business Overview
9.6.5 Crown Bioscience, Inc. Recent Developments
9.7 Indivumed GmbH
9.7.1 Indivumed GmbH Viable Tumor Samples Basic Information
9.7.2 Indivumed GmbH Viable Tumor Samples Product Overview
9.7.3 Indivumed GmbH Viable Tumor Samples Product Market Performance
9.7.4 Indivumed GmbH Business Overview
9.7.5 Indivumed GmbH Recent Developments
9.8 Illumina, Inc.
9.8.1 Illumina, Inc. Viable Tumor Samples Basic Information
9.8.2 Illumina, Inc. Viable Tumor Samples Product Overview
9.8.3 Illumina, Inc. Viable Tumor Samples Product Market Performance
9.8.4 Illumina, Inc. Business Overview
9.8.5 Illumina, Inc. Recent Developments
9.9 QIAGEN NV
9.9.1 QIAGEN NV Viable Tumor Samples Basic Information
9.9.2 QIAGEN NV Viable Tumor Samples Product Overview
9.9.3 QIAGEN NV Viable Tumor Samples Product Market Performance
9.9.4 QIAGEN NV Business Overview
9.9.5 QIAGEN NV Recent Developments
9.10 Neogenomics Laboratories, Inc.
9.10.1 Neogenomics Laboratories, Inc. Viable Tumor Samples Basic Information
9.10.2 Neogenomics Laboratories, Inc. Viable Tumor Samples Product Overview
9.10.3 Neogenomics Laboratories, Inc. Viable Tumor Samples Product Market Performance
9.10.4 Neogenomics Laboratories, Inc. Business Overview
9.10.5 Neogenomics Laboratories, Inc. Recent Developments
9.11 HTG Molecular Diagnostics
9.11.1 HTG Molecular Diagnostics Viable Tumor Samples Basic Information
9.11.2 HTG Molecular Diagnostics Viable Tumor Samples Product Overview
9.11.3 HTG Molecular Diagnostics Viable Tumor Samples Product Market Performance
9.11.4 HTG Molecular Diagnostics Business Overview
9.11.5 HTG Molecular Diagnostics Recent Developments
9.12 Genomic Health, Inc.
9.12.1 Genomic Health, Inc. Viable Tumor Samples Basic Information
9.12.2 Genomic Health, Inc. Viable Tumor Samples Product Overview
9.12.3 Genomic Health, Inc. Viable Tumor Samples Product Market Performance
9.12.4 Genomic Health, Inc. Business Overview
9.12.5 Genomic Health, Inc. Recent Developments
9.13 Thermo Fischer
9.13.1 Thermo Fischer Viable Tumor Samples Basic Information
9.13.2 Thermo Fischer Viable Tumor Samples Product Overview
9.13.3 Thermo Fischer Viable Tumor Samples Product Market Performance
9.13.4 Thermo Fischer Business Overview
9.13.5 Thermo Fischer Recent Developments
9.14 BGI Genomics Co., Ltd.
9.14.1 BGI Genomics Co., Ltd. Viable Tumor Samples Basic Information
9.14.2 BGI Genomics Co., Ltd. Viable Tumor Samples Product Overview
9.14.3 BGI Genomics Co., Ltd. Viable Tumor Samples Product Market Performance
9.14.4 BGI Genomics Co., Ltd. Business Overview
9.14.5 BGI Genomics Co., Ltd. Recent Developments
9.15 Bruker Biosciences Corp.
9.15.1 Bruker Biosciences Corp. Viable Tumor Samples Basic Information
9.15.2 Bruker Biosciences Corp. Viable Tumor Samples Product Overview
9.15.3 Bruker Biosciences Corp. Viable Tumor Samples Product Market Performance
9.15.4 Bruker Biosciences Corp. Business Overview
9.15.5 Bruker Biosciences Corp. Recent Developments
9.16 Cepheid, Inc.
9.16.1 Cepheid, Inc. Viable Tumor Samples Basic Information
9.16.2 Cepheid, Inc. Viable Tumor Samples Product Overview
9.16.3 Cepheid, Inc. Viable Tumor Samples Product Market Performance
9.16.4 Cepheid, Inc. Business Overview
9.16.5 Cepheid, Inc. Recent Developments
9.17 Promega Corporation
9.17.1 Promega Corporation Viable Tumor Samples Basic Information
9.17.2 Promega Corporation Viable Tumor Samples Product Overview
9.17.3 Promega Corporation Viable Tumor Samples Product Market Performance
9.17.4 Promega Corporation Business Overview
9.17.5 Promega Corporation Recent Developments
9.18 Applied Biosystems, Inc.
9.18.1 Applied Biosystems, Inc. Viable Tumor Samples Basic Information
9.18.2 Applied Biosystems, Inc. Viable Tumor Samples Product Overview
9.18.3 Applied Biosystems, Inc. Viable Tumor Samples Product Market Performance
9.18.4 Applied Biosystems, Inc. Business Overview
9.18.5 Applied Biosystems, Inc. Recent Developments
9.19 Natera
9.19.1 Natera Viable Tumor Samples Basic Information
9.19.2 Natera Viable Tumor Samples Product Overview
9.19.3 Natera Viable Tumor Samples Product Market Performance
9.19.4 Natera Business Overview
9.19.5 Natera Recent Developments
9.20 Agilent
9.20.1 Agilent Viable Tumor Samples Basic Information
9.20.2 Agilent Viable Tumor Samples Product Overview
9.20.3 Agilent Viable Tumor Samples Product Market Performance
9.20.4 Agilent Business Overview
9.20.5 Agilent Recent Developments
10 VIABLE TUMOR SAMPLES MARKET FORECAST BY REGION
10.1 Global Viable Tumor Samples Market Size Forecast
10.2 Global Viable Tumor Samples Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viable Tumor Samples Market Size Forecast by Country
10.2.3 Asia Pacific Viable Tumor Samples Market Size Forecast by Region
10.2.4 South America Viable Tumor Samples Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viable Tumor Samples by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Viable Tumor Samples Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Viable Tumor Samples by Type (2025-2030)
11.1.2 Global Viable Tumor Samples Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Viable Tumor Samples by Type (2025-2030)
11.2 Global Viable Tumor Samples Market Forecast by Application (2025-2030)
11.2.1 Global Viable Tumor Samples Sales (K Units) Forecast by Application
11.2.2 Global Viable Tumor Samples Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Viable Tumor Samples
1.2 Key Market Segments
1.2.1 Viable Tumor Samples Segment by Type
1.2.2 Viable Tumor Samples Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 VIABLE TUMOR SAMPLES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Viable Tumor Samples Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Viable Tumor Samples Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 VIABLE TUMOR SAMPLES MARKET COMPETITIVE LANDSCAPE
3.1 Global Viable Tumor Samples Sales by Manufacturers (2019-2024)
3.2 Global Viable Tumor Samples Revenue Market Share by Manufacturers (2019-2024)
3.3 Viable Tumor Samples Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Viable Tumor Samples Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Viable Tumor Samples Sales Sites, Area Served, Product Type
3.6 Viable Tumor Samples Market Competitive Situation and Trends
3.6.1 Viable Tumor Samples Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viable Tumor Samples Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 VIABLE TUMOR SAMPLES INDUSTRY CHAIN ANALYSIS
4.1 Viable Tumor Samples Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF VIABLE TUMOR SAMPLES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 VIABLE TUMOR SAMPLES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viable Tumor Samples Sales Market Share by Type (2019-2024)
6.3 Global Viable Tumor Samples Market Size Market Share by Type (2019-2024)
6.4 Global Viable Tumor Samples Price by Type (2019-2024)
7 VIABLE TUMOR SAMPLES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viable Tumor Samples Market Sales by Application (2019-2024)
7.3 Global Viable Tumor Samples Market Size (M USD) by Application (2019-2024)
7.4 Global Viable Tumor Samples Sales Growth Rate by Application (2019-2024)
8 VIABLE TUMOR SAMPLES MARKET SEGMENTATION BY REGION
8.1 Global Viable Tumor Samples Sales by Region
8.1.1 Global Viable Tumor Samples Sales by Region
8.1.2 Global Viable Tumor Samples Sales Market Share by Region
8.2 North America
8.2.1 North America Viable Tumor Samples Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viable Tumor Samples Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viable Tumor Samples Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viable Tumor Samples Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viable Tumor Samples Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 StoreMyTumor
9.1.1 StoreMyTumor Viable Tumor Samples Basic Information
9.1.2 StoreMyTumor Viable Tumor Samples Product Overview
9.1.3 StoreMyTumor Viable Tumor Samples Product Market Performance
9.1.4 StoreMyTumor Business Overview
9.1.5 StoreMyTumor Viable Tumor Samples SWOT Analysis
9.1.6 StoreMyTumor Recent Developments
9.2 Cureline, Inc.
9.2.1 Cureline, Inc. Viable Tumor Samples Basic Information
9.2.2 Cureline, Inc. Viable Tumor Samples Product Overview
9.2.3 Cureline, Inc. Viable Tumor Samples Product Market Performance
9.2.4 Cureline, Inc. Business Overview
9.2.5 Cureline, Inc. Viable Tumor Samples SWOT Analysis
9.2.6 Cureline, Inc. Recent Developments
9.3 Conversant Bio
9.3.1 Conversant Bio Viable Tumor Samples Basic Information
9.3.2 Conversant Bio Viable Tumor Samples Product Overview
9.3.3 Conversant Bio Viable Tumor Samples Product Market Performance
9.3.4 Conversant Bio Viable Tumor Samples SWOT Analysis
9.3.5 Conversant Bio Business Overview
9.3.6 Conversant Bio Recent Developments
9.4 Fluxion Biosciences
9.4.1 Fluxion Biosciences Viable Tumor Samples Basic Information
9.4.2 Fluxion Biosciences Viable Tumor Samples Product Overview
9.4.3 Fluxion Biosciences Viable Tumor Samples Product Market Performance
9.4.4 Fluxion Biosciences Business Overview
9.4.5 Fluxion Biosciences Recent Developments
9.5 Miltenyi Biotech
9.5.1 Miltenyi Biotech Viable Tumor Samples Basic Information
9.5.2 Miltenyi Biotech Viable Tumor Samples Product Overview
9.5.3 Miltenyi Biotech Viable Tumor Samples Product Market Performance
9.5.4 Miltenyi Biotech Business Overview
9.5.5 Miltenyi Biotech Recent Developments
9.6 Crown Bioscience, Inc.
9.6.1 Crown Bioscience, Inc. Viable Tumor Samples Basic Information
9.6.2 Crown Bioscience, Inc. Viable Tumor Samples Product Overview
9.6.3 Crown Bioscience, Inc. Viable Tumor Samples Product Market Performance
9.6.4 Crown Bioscience, Inc. Business Overview
9.6.5 Crown Bioscience, Inc. Recent Developments
9.7 Indivumed GmbH
9.7.1 Indivumed GmbH Viable Tumor Samples Basic Information
9.7.2 Indivumed GmbH Viable Tumor Samples Product Overview
9.7.3 Indivumed GmbH Viable Tumor Samples Product Market Performance
9.7.4 Indivumed GmbH Business Overview
9.7.5 Indivumed GmbH Recent Developments
9.8 Illumina, Inc.
9.8.1 Illumina, Inc. Viable Tumor Samples Basic Information
9.8.2 Illumina, Inc. Viable Tumor Samples Product Overview
9.8.3 Illumina, Inc. Viable Tumor Samples Product Market Performance
9.8.4 Illumina, Inc. Business Overview
9.8.5 Illumina, Inc. Recent Developments
9.9 QIAGEN NV
9.9.1 QIAGEN NV Viable Tumor Samples Basic Information
9.9.2 QIAGEN NV Viable Tumor Samples Product Overview
9.9.3 QIAGEN NV Viable Tumor Samples Product Market Performance
9.9.4 QIAGEN NV Business Overview
9.9.5 QIAGEN NV Recent Developments
9.10 Neogenomics Laboratories, Inc.
9.10.1 Neogenomics Laboratories, Inc. Viable Tumor Samples Basic Information
9.10.2 Neogenomics Laboratories, Inc. Viable Tumor Samples Product Overview
9.10.3 Neogenomics Laboratories, Inc. Viable Tumor Samples Product Market Performance
9.10.4 Neogenomics Laboratories, Inc. Business Overview
9.10.5 Neogenomics Laboratories, Inc. Recent Developments
9.11 HTG Molecular Diagnostics
9.11.1 HTG Molecular Diagnostics Viable Tumor Samples Basic Information
9.11.2 HTG Molecular Diagnostics Viable Tumor Samples Product Overview
9.11.3 HTG Molecular Diagnostics Viable Tumor Samples Product Market Performance
9.11.4 HTG Molecular Diagnostics Business Overview
9.11.5 HTG Molecular Diagnostics Recent Developments
9.12 Genomic Health, Inc.
9.12.1 Genomic Health, Inc. Viable Tumor Samples Basic Information
9.12.2 Genomic Health, Inc. Viable Tumor Samples Product Overview
9.12.3 Genomic Health, Inc. Viable Tumor Samples Product Market Performance
9.12.4 Genomic Health, Inc. Business Overview
9.12.5 Genomic Health, Inc. Recent Developments
9.13 Thermo Fischer
9.13.1 Thermo Fischer Viable Tumor Samples Basic Information
9.13.2 Thermo Fischer Viable Tumor Samples Product Overview
9.13.3 Thermo Fischer Viable Tumor Samples Product Market Performance
9.13.4 Thermo Fischer Business Overview
9.13.5 Thermo Fischer Recent Developments
9.14 BGI Genomics Co., Ltd.
9.14.1 BGI Genomics Co., Ltd. Viable Tumor Samples Basic Information
9.14.2 BGI Genomics Co., Ltd. Viable Tumor Samples Product Overview
9.14.3 BGI Genomics Co., Ltd. Viable Tumor Samples Product Market Performance
9.14.4 BGI Genomics Co., Ltd. Business Overview
9.14.5 BGI Genomics Co., Ltd. Recent Developments
9.15 Bruker Biosciences Corp.
9.15.1 Bruker Biosciences Corp. Viable Tumor Samples Basic Information
9.15.2 Bruker Biosciences Corp. Viable Tumor Samples Product Overview
9.15.3 Bruker Biosciences Corp. Viable Tumor Samples Product Market Performance
9.15.4 Bruker Biosciences Corp. Business Overview
9.15.5 Bruker Biosciences Corp. Recent Developments
9.16 Cepheid, Inc.
9.16.1 Cepheid, Inc. Viable Tumor Samples Basic Information
9.16.2 Cepheid, Inc. Viable Tumor Samples Product Overview
9.16.3 Cepheid, Inc. Viable Tumor Samples Product Market Performance
9.16.4 Cepheid, Inc. Business Overview
9.16.5 Cepheid, Inc. Recent Developments
9.17 Promega Corporation
9.17.1 Promega Corporation Viable Tumor Samples Basic Information
9.17.2 Promega Corporation Viable Tumor Samples Product Overview
9.17.3 Promega Corporation Viable Tumor Samples Product Market Performance
9.17.4 Promega Corporation Business Overview
9.17.5 Promega Corporation Recent Developments
9.18 Applied Biosystems, Inc.
9.18.1 Applied Biosystems, Inc. Viable Tumor Samples Basic Information
9.18.2 Applied Biosystems, Inc. Viable Tumor Samples Product Overview
9.18.3 Applied Biosystems, Inc. Viable Tumor Samples Product Market Performance
9.18.4 Applied Biosystems, Inc. Business Overview
9.18.5 Applied Biosystems, Inc. Recent Developments
9.19 Natera
9.19.1 Natera Viable Tumor Samples Basic Information
9.19.2 Natera Viable Tumor Samples Product Overview
9.19.3 Natera Viable Tumor Samples Product Market Performance
9.19.4 Natera Business Overview
9.19.5 Natera Recent Developments
9.20 Agilent
9.20.1 Agilent Viable Tumor Samples Basic Information
9.20.2 Agilent Viable Tumor Samples Product Overview
9.20.3 Agilent Viable Tumor Samples Product Market Performance
9.20.4 Agilent Business Overview
9.20.5 Agilent Recent Developments
10 VIABLE TUMOR SAMPLES MARKET FORECAST BY REGION
10.1 Global Viable Tumor Samples Market Size Forecast
10.2 Global Viable Tumor Samples Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viable Tumor Samples Market Size Forecast by Country
10.2.3 Asia Pacific Viable Tumor Samples Market Size Forecast by Region
10.2.4 South America Viable Tumor Samples Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viable Tumor Samples by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Viable Tumor Samples Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Viable Tumor Samples by Type (2025-2030)
11.1.2 Global Viable Tumor Samples Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Viable Tumor Samples by Type (2025-2030)
11.2 Global Viable Tumor Samples Market Forecast by Application (2025-2030)
11.2.1 Global Viable Tumor Samples Sales (K Units) Forecast by Application
11.2.2 Global Viable Tumor Samples Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Viable Tumor Samples Market Size Comparison by Region (M USD)
Table 5. Global Viable Tumor Samples Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Viable Tumor Samples Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Viable Tumor Samples Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Viable Tumor Samples Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viable Tumor Samples as of 2022)
Table 10. Global Market Viable Tumor Samples Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Viable Tumor Samples Sales Sites and Area Served
Table 12. Manufacturers Viable Tumor Samples Product Type
Table 13. Global Viable Tumor Samples Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Viable Tumor Samples
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Viable Tumor Samples Market Challenges
Table 22. Global Viable Tumor Samples Sales by Type (K Units)
Table 23. Global Viable Tumor Samples Market Size by Type (M USD)
Table 24. Global Viable Tumor Samples Sales (K Units) by Type (2019-2024)
Table 25. Global Viable Tumor Samples Sales Market Share by Type (2019-2024)
Table 26. Global Viable Tumor Samples Market Size (M USD) by Type (2019-2024)
Table 27. Global Viable Tumor Samples Market Size Share by Type (2019-2024)
Table 28. Global Viable Tumor Samples Price (USD/Unit) by Type (2019-2024)
Table 29. Global Viable Tumor Samples Sales (K Units) by Application
Table 30. Global Viable Tumor Samples Market Size by Application
Table 31. Global Viable Tumor Samples Sales by Application (2019-2024) & (K Units)
Table 32. Global Viable Tumor Samples Sales Market Share by Application (2019-2024)
Table 33. Global Viable Tumor Samples Sales by Application (2019-2024) & (M USD)
Table 34. Global Viable Tumor Samples Market Share by Application (2019-2024)
Table 35. Global Viable Tumor Samples Sales Growth Rate by Application (2019-2024)
Table 36. Global Viable Tumor Samples Sales by Region (2019-2024) & (K Units)
Table 37. Global Viable Tumor Samples Sales Market Share by Region (2019-2024)
Table 38. North America Viable Tumor Samples Sales by Country (2019-2024) & (K Units)
Table 39. Europe Viable Tumor Samples Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Viable Tumor Samples Sales by Region (2019-2024) & (K Units)
Table 41. South America Viable Tumor Samples Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Viable Tumor Samples Sales by Region (2019-2024) & (K Units)
Table 43. StoreMyTumor Viable Tumor Samples Basic Information
Table 44. StoreMyTumor Viable Tumor Samples Product Overview
Table 45. StoreMyTumor Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. StoreMyTumor Business Overview
Table 47. StoreMyTumor Viable Tumor Samples SWOT Analysis
Table 48. StoreMyTumor Recent Developments
Table 49. Cureline, Inc. Viable Tumor Samples Basic Information
Table 50. Cureline, Inc. Viable Tumor Samples Product Overview
Table 51. Cureline, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Cureline, Inc. Business Overview
Table 53. Cureline, Inc. Viable Tumor Samples SWOT Analysis
Table 54. Cureline, Inc. Recent Developments
Table 55. Conversant Bio Viable Tumor Samples Basic Information
Table 56. Conversant Bio Viable Tumor Samples Product Overview
Table 57. Conversant Bio Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Conversant Bio Viable Tumor Samples SWOT Analysis
Table 59. Conversant Bio Business Overview
Table 60. Conversant Bio Recent Developments
Table 61. Fluxion Biosciences Viable Tumor Samples Basic Information
Table 62. Fluxion Biosciences Viable Tumor Samples Product Overview
Table 63. Fluxion Biosciences Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Fluxion Biosciences Business Overview
Table 65. Fluxion Biosciences Recent Developments
Table 66. Miltenyi Biotech Viable Tumor Samples Basic Information
Table 67. Miltenyi Biotech Viable Tumor Samples Product Overview
Table 68. Miltenyi Biotech Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Miltenyi Biotech Business Overview
Table 70. Miltenyi Biotech Recent Developments
Table 71. Crown Bioscience, Inc. Viable Tumor Samples Basic Information
Table 72. Crown Bioscience, Inc. Viable Tumor Samples Product Overview
Table 73. Crown Bioscience, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Crown Bioscience, Inc. Business Overview
Table 75. Crown Bioscience, Inc. Recent Developments
Table 76. Indivumed GmbH Viable Tumor Samples Basic Information
Table 77. Indivumed GmbH Viable Tumor Samples Product Overview
Table 78. Indivumed GmbH Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Indivumed GmbH Business Overview
Table 80. Indivumed GmbH Recent Developments
Table 81. Illumina, Inc. Viable Tumor Samples Basic Information
Table 82. Illumina, Inc. Viable Tumor Samples Product Overview
Table 83. Illumina, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Illumina, Inc. Business Overview
Table 85. Illumina, Inc. Recent Developments
Table 86. QIAGEN NV Viable Tumor Samples Basic Information
Table 87. QIAGEN NV Viable Tumor Samples Product Overview
Table 88. QIAGEN NV Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. QIAGEN NV Business Overview
Table 90. QIAGEN NV Recent Developments
Table 91. Neogenomics Laboratories, Inc. Viable Tumor Samples Basic Information
Table 92. Neogenomics Laboratories, Inc. Viable Tumor Samples Product Overview
Table 93. Neogenomics Laboratories, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Neogenomics Laboratories, Inc. Business Overview
Table 95. Neogenomics Laboratories, Inc. Recent Developments
Table 96. HTG Molecular Diagnostics Viable Tumor Samples Basic Information
Table 97. HTG Molecular Diagnostics Viable Tumor Samples Product Overview
Table 98. HTG Molecular Diagnostics Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. HTG Molecular Diagnostics Business Overview
Table 100. HTG Molecular Diagnostics Recent Developments
Table 101. Genomic Health, Inc. Viable Tumor Samples Basic Information
Table 102. Genomic Health, Inc. Viable Tumor Samples Product Overview
Table 103. Genomic Health, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Genomic Health, Inc. Business Overview
Table 105. Genomic Health, Inc. Recent Developments
Table 106. Thermo Fischer Viable Tumor Samples Basic Information
Table 107. Thermo Fischer Viable Tumor Samples Product Overview
Table 108. Thermo Fischer Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Thermo Fischer Business Overview
Table 110. Thermo Fischer Recent Developments
Table 111. BGI Genomics Co., Ltd. Viable Tumor Samples Basic Information
Table 112. BGI Genomics Co., Ltd. Viable Tumor Samples Product Overview
Table 113. BGI Genomics Co., Ltd. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. BGI Genomics Co., Ltd. Business Overview
Table 115. BGI Genomics Co., Ltd. Recent Developments
Table 116. Bruker Biosciences Corp. Viable Tumor Samples Basic Information
Table 117. Bruker Biosciences Corp. Viable Tumor Samples Product Overview
Table 118. Bruker Biosciences Corp. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Bruker Biosciences Corp. Business Overview
Table 120. Bruker Biosciences Corp. Recent Developments
Table 121. Cepheid, Inc. Viable Tumor Samples Basic Information
Table 122. Cepheid, Inc. Viable Tumor Samples Product Overview
Table 123. Cepheid, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Cepheid, Inc. Business Overview
Table 125. Cepheid, Inc. Recent Developments
Table 126. Promega Corporation Viable Tumor Samples Basic Information
Table 127. Promega Corporation Viable Tumor Samples Product Overview
Table 128. Promega Corporation Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Promega Corporation Business Overview
Table 130. Promega Corporation Recent Developments
Table 131. Applied Biosystems, Inc. Viable Tumor Samples Basic Information
Table 132. Applied Biosystems, Inc. Viable Tumor Samples Product Overview
Table 133. Applied Biosystems, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Applied Biosystems, Inc. Business Overview
Table 135. Applied Biosystems, Inc. Recent Developments
Table 136. Natera Viable Tumor Samples Basic Information
Table 137. Natera Viable Tumor Samples Product Overview
Table 138. Natera Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Natera Business Overview
Table 140. Natera Recent Developments
Table 141. Agilent Viable Tumor Samples Basic Information
Table 142. Agilent Viable Tumor Samples Product Overview
Table 143. Agilent Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Agilent Business Overview
Table 145. Agilent Recent Developments
Table 146. Global Viable Tumor Samples Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global Viable Tumor Samples Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Viable Tumor Samples Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America Viable Tumor Samples Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Viable Tumor Samples Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe Viable Tumor Samples Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Viable Tumor Samples Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific Viable Tumor Samples Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Viable Tumor Samples Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America Viable Tumor Samples Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Viable Tumor Samples Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Viable Tumor Samples Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Viable Tumor Samples Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global Viable Tumor Samples Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Viable Tumor Samples Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global Viable Tumor Samples Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global Viable Tumor Samples Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Viable Tumor Samples Market Size Comparison by Region (M USD)
Table 5. Global Viable Tumor Samples Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Viable Tumor Samples Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Viable Tumor Samples Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Viable Tumor Samples Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viable Tumor Samples as of 2022)
Table 10. Global Market Viable Tumor Samples Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Viable Tumor Samples Sales Sites and Area Served
Table 12. Manufacturers Viable Tumor Samples Product Type
Table 13. Global Viable Tumor Samples Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Viable Tumor Samples
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Viable Tumor Samples Market Challenges
Table 22. Global Viable Tumor Samples Sales by Type (K Units)
Table 23. Global Viable Tumor Samples Market Size by Type (M USD)
Table 24. Global Viable Tumor Samples Sales (K Units) by Type (2019-2024)
Table 25. Global Viable Tumor Samples Sales Market Share by Type (2019-2024)
Table 26. Global Viable Tumor Samples Market Size (M USD) by Type (2019-2024)
Table 27. Global Viable Tumor Samples Market Size Share by Type (2019-2024)
Table 28. Global Viable Tumor Samples Price (USD/Unit) by Type (2019-2024)
Table 29. Global Viable Tumor Samples Sales (K Units) by Application
Table 30. Global Viable Tumor Samples Market Size by Application
Table 31. Global Viable Tumor Samples Sales by Application (2019-2024) & (K Units)
Table 32. Global Viable Tumor Samples Sales Market Share by Application (2019-2024)
Table 33. Global Viable Tumor Samples Sales by Application (2019-2024) & (M USD)
Table 34. Global Viable Tumor Samples Market Share by Application (2019-2024)
Table 35. Global Viable Tumor Samples Sales Growth Rate by Application (2019-2024)
Table 36. Global Viable Tumor Samples Sales by Region (2019-2024) & (K Units)
Table 37. Global Viable Tumor Samples Sales Market Share by Region (2019-2024)
Table 38. North America Viable Tumor Samples Sales by Country (2019-2024) & (K Units)
Table 39. Europe Viable Tumor Samples Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Viable Tumor Samples Sales by Region (2019-2024) & (K Units)
Table 41. South America Viable Tumor Samples Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Viable Tumor Samples Sales by Region (2019-2024) & (K Units)
Table 43. StoreMyTumor Viable Tumor Samples Basic Information
Table 44. StoreMyTumor Viable Tumor Samples Product Overview
Table 45. StoreMyTumor Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. StoreMyTumor Business Overview
Table 47. StoreMyTumor Viable Tumor Samples SWOT Analysis
Table 48. StoreMyTumor Recent Developments
Table 49. Cureline, Inc. Viable Tumor Samples Basic Information
Table 50. Cureline, Inc. Viable Tumor Samples Product Overview
Table 51. Cureline, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Cureline, Inc. Business Overview
Table 53. Cureline, Inc. Viable Tumor Samples SWOT Analysis
Table 54. Cureline, Inc. Recent Developments
Table 55. Conversant Bio Viable Tumor Samples Basic Information
Table 56. Conversant Bio Viable Tumor Samples Product Overview
Table 57. Conversant Bio Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Conversant Bio Viable Tumor Samples SWOT Analysis
Table 59. Conversant Bio Business Overview
Table 60. Conversant Bio Recent Developments
Table 61. Fluxion Biosciences Viable Tumor Samples Basic Information
Table 62. Fluxion Biosciences Viable Tumor Samples Product Overview
Table 63. Fluxion Biosciences Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Fluxion Biosciences Business Overview
Table 65. Fluxion Biosciences Recent Developments
Table 66. Miltenyi Biotech Viable Tumor Samples Basic Information
Table 67. Miltenyi Biotech Viable Tumor Samples Product Overview
Table 68. Miltenyi Biotech Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Miltenyi Biotech Business Overview
Table 70. Miltenyi Biotech Recent Developments
Table 71. Crown Bioscience, Inc. Viable Tumor Samples Basic Information
Table 72. Crown Bioscience, Inc. Viable Tumor Samples Product Overview
Table 73. Crown Bioscience, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Crown Bioscience, Inc. Business Overview
Table 75. Crown Bioscience, Inc. Recent Developments
Table 76. Indivumed GmbH Viable Tumor Samples Basic Information
Table 77. Indivumed GmbH Viable Tumor Samples Product Overview
Table 78. Indivumed GmbH Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Indivumed GmbH Business Overview
Table 80. Indivumed GmbH Recent Developments
Table 81. Illumina, Inc. Viable Tumor Samples Basic Information
Table 82. Illumina, Inc. Viable Tumor Samples Product Overview
Table 83. Illumina, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Illumina, Inc. Business Overview
Table 85. Illumina, Inc. Recent Developments
Table 86. QIAGEN NV Viable Tumor Samples Basic Information
Table 87. QIAGEN NV Viable Tumor Samples Product Overview
Table 88. QIAGEN NV Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. QIAGEN NV Business Overview
Table 90. QIAGEN NV Recent Developments
Table 91. Neogenomics Laboratories, Inc. Viable Tumor Samples Basic Information
Table 92. Neogenomics Laboratories, Inc. Viable Tumor Samples Product Overview
Table 93. Neogenomics Laboratories, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Neogenomics Laboratories, Inc. Business Overview
Table 95. Neogenomics Laboratories, Inc. Recent Developments
Table 96. HTG Molecular Diagnostics Viable Tumor Samples Basic Information
Table 97. HTG Molecular Diagnostics Viable Tumor Samples Product Overview
Table 98. HTG Molecular Diagnostics Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. HTG Molecular Diagnostics Business Overview
Table 100. HTG Molecular Diagnostics Recent Developments
Table 101. Genomic Health, Inc. Viable Tumor Samples Basic Information
Table 102. Genomic Health, Inc. Viable Tumor Samples Product Overview
Table 103. Genomic Health, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Genomic Health, Inc. Business Overview
Table 105. Genomic Health, Inc. Recent Developments
Table 106. Thermo Fischer Viable Tumor Samples Basic Information
Table 107. Thermo Fischer Viable Tumor Samples Product Overview
Table 108. Thermo Fischer Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Thermo Fischer Business Overview
Table 110. Thermo Fischer Recent Developments
Table 111. BGI Genomics Co., Ltd. Viable Tumor Samples Basic Information
Table 112. BGI Genomics Co., Ltd. Viable Tumor Samples Product Overview
Table 113. BGI Genomics Co., Ltd. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. BGI Genomics Co., Ltd. Business Overview
Table 115. BGI Genomics Co., Ltd. Recent Developments
Table 116. Bruker Biosciences Corp. Viable Tumor Samples Basic Information
Table 117. Bruker Biosciences Corp. Viable Tumor Samples Product Overview
Table 118. Bruker Biosciences Corp. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. Bruker Biosciences Corp. Business Overview
Table 120. Bruker Biosciences Corp. Recent Developments
Table 121. Cepheid, Inc. Viable Tumor Samples Basic Information
Table 122. Cepheid, Inc. Viable Tumor Samples Product Overview
Table 123. Cepheid, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Cepheid, Inc. Business Overview
Table 125. Cepheid, Inc. Recent Developments
Table 126. Promega Corporation Viable Tumor Samples Basic Information
Table 127. Promega Corporation Viable Tumor Samples Product Overview
Table 128. Promega Corporation Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Promega Corporation Business Overview
Table 130. Promega Corporation Recent Developments
Table 131. Applied Biosystems, Inc. Viable Tumor Samples Basic Information
Table 132. Applied Biosystems, Inc. Viable Tumor Samples Product Overview
Table 133. Applied Biosystems, Inc. Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Applied Biosystems, Inc. Business Overview
Table 135. Applied Biosystems, Inc. Recent Developments
Table 136. Natera Viable Tumor Samples Basic Information
Table 137. Natera Viable Tumor Samples Product Overview
Table 138. Natera Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. Natera Business Overview
Table 140. Natera Recent Developments
Table 141. Agilent Viable Tumor Samples Basic Information
Table 142. Agilent Viable Tumor Samples Product Overview
Table 143. Agilent Viable Tumor Samples Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. Agilent Business Overview
Table 145. Agilent Recent Developments
Table 146. Global Viable Tumor Samples Sales Forecast by Region (2025-2030) & (K Units)
Table 147. Global Viable Tumor Samples Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Viable Tumor Samples Sales Forecast by Country (2025-2030) & (K Units)
Table 149. North America Viable Tumor Samples Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Viable Tumor Samples Sales Forecast by Country (2025-2030) & (K Units)
Table 151. Europe Viable Tumor Samples Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Viable Tumor Samples Sales Forecast by Region (2025-2030) & (K Units)
Table 153. Asia Pacific Viable Tumor Samples Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Viable Tumor Samples Sales Forecast by Country (2025-2030) & (K Units)
Table 155. South America Viable Tumor Samples Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Viable Tumor Samples Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Viable Tumor Samples Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Viable Tumor Samples Sales Forecast by Type (2025-2030) & (K Units)
Table 159. Global Viable Tumor Samples Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Viable Tumor Samples Price Forecast by Type (2025-2030) & (USD/Unit)
Table 161. Global Viable Tumor Samples Sales (K Units) Forecast by Application (2025-2030)
Table 162. Global Viable Tumor Samples Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Viable Tumor Samples
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viable Tumor Samples Market Size (M USD), 2019-2030
Figure 5. Global Viable Tumor Samples Market Size (M USD) (2019-2030)
Figure 6. Global Viable Tumor Samples Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Viable Tumor Samples Market Size by Country (M USD)
Figure 11. Viable Tumor Samples Sales Share by Manufacturers in 2023
Figure 12. Global Viable Tumor Samples Revenue Share by Manufacturers in 2023
Figure 13. Viable Tumor Samples Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Viable Tumor Samples Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Viable Tumor Samples Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Viable Tumor Samples Market Share by Type
Figure 18. Sales Market Share of Viable Tumor Samples by Type (2019-2024)
Figure 19. Sales Market Share of Viable Tumor Samples by Type in 2023
Figure 20. Market Size Share of Viable Tumor Samples by Type (2019-2024)
Figure 21. Market Size Market Share of Viable Tumor Samples by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Viable Tumor Samples Market Share by Application
Figure 24. Global Viable Tumor Samples Sales Market Share by Application (2019-2024)
Figure 25. Global Viable Tumor Samples Sales Market Share by Application in 2023
Figure 26. Global Viable Tumor Samples Market Share by Application (2019-2024)
Figure 27. Global Viable Tumor Samples Market Share by Application in 2023
Figure 28. Global Viable Tumor Samples Sales Growth Rate by Application (2019-2024)
Figure 29. Global Viable Tumor Samples Sales Market Share by Region (2019-2024)
Figure 30. North America Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Viable Tumor Samples Sales Market Share by Country in 2023
Figure 32. U.S. Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Viable Tumor Samples Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Viable Tumor Samples Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Viable Tumor Samples Sales Market Share by Country in 2023
Figure 37. Germany Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Viable Tumor Samples Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Viable Tumor Samples Sales Market Share by Region in 2023
Figure 44. China Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Viable Tumor Samples Sales and Growth Rate (K Units)
Figure 50. South America Viable Tumor Samples Sales Market Share by Country in 2023
Figure 51. Brazil Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Viable Tumor Samples Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Viable Tumor Samples Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Viable Tumor Samples Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Viable Tumor Samples Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Viable Tumor Samples Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Viable Tumor Samples Market Share Forecast by Type (2025-2030)
Figure 65. Global Viable Tumor Samples Sales Forecast by Application (2025-2030)
Figure 66. Global Viable Tumor Samples Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Viable Tumor Samples
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Viable Tumor Samples Market Size (M USD), 2019-2030
Figure 5. Global Viable Tumor Samples Market Size (M USD) (2019-2030)
Figure 6. Global Viable Tumor Samples Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Viable Tumor Samples Market Size by Country (M USD)
Figure 11. Viable Tumor Samples Sales Share by Manufacturers in 2023
Figure 12. Global Viable Tumor Samples Revenue Share by Manufacturers in 2023
Figure 13. Viable Tumor Samples Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Viable Tumor Samples Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Viable Tumor Samples Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Viable Tumor Samples Market Share by Type
Figure 18. Sales Market Share of Viable Tumor Samples by Type (2019-2024)
Figure 19. Sales Market Share of Viable Tumor Samples by Type in 2023
Figure 20. Market Size Share of Viable Tumor Samples by Type (2019-2024)
Figure 21. Market Size Market Share of Viable Tumor Samples by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Viable Tumor Samples Market Share by Application
Figure 24. Global Viable Tumor Samples Sales Market Share by Application (2019-2024)
Figure 25. Global Viable Tumor Samples Sales Market Share by Application in 2023
Figure 26. Global Viable Tumor Samples Market Share by Application (2019-2024)
Figure 27. Global Viable Tumor Samples Market Share by Application in 2023
Figure 28. Global Viable Tumor Samples Sales Growth Rate by Application (2019-2024)
Figure 29. Global Viable Tumor Samples Sales Market Share by Region (2019-2024)
Figure 30. North America Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Viable Tumor Samples Sales Market Share by Country in 2023
Figure 32. U.S. Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Viable Tumor Samples Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Viable Tumor Samples Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Viable Tumor Samples Sales Market Share by Country in 2023
Figure 37. Germany Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Viable Tumor Samples Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Viable Tumor Samples Sales Market Share by Region in 2023
Figure 44. China Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Viable Tumor Samples Sales and Growth Rate (K Units)
Figure 50. South America Viable Tumor Samples Sales Market Share by Country in 2023
Figure 51. Brazil Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Viable Tumor Samples Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Viable Tumor Samples Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Viable Tumor Samples Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Viable Tumor Samples Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Viable Tumor Samples Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Viable Tumor Samples Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Viable Tumor Samples Market Share Forecast by Type (2025-2030)
Figure 65. Global Viable Tumor Samples Sales Forecast by Application (2025-2030)
Figure 66. Global Viable Tumor Samples Market Share Forecast by Application (2025-2030)
